Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Veranova Names Mike Riley CEO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Veranova Names Mike Riley CEO

Riley has almost 20 years of experience in the CDMO industry.

By: Anthony Vecchione

Veranova, a provider of process development and manufacturing of APIs, appointed Mike Riley Chief Executive Officer. Riley will assume responsibility for Veranova’s global business, effective Monday, May 8, and will report directly to the Veranova Board of Directors.

Riley is a seasoned executive, with over 25 years of professional experience, of which nearly 19 years have been spent in the pharmaceutical contract development and manufacturing operations (CDMO) industry building, leading, and growing global businesses. Most recently, Riley served at Catalent, Inc., as president of the biotherapeutics business, a multi-site business unit with 6,500 employees and revenue over $1 billion.



In a statement, the company said that Riley’s extensive knowledge of the life-sciences and CDMO industry, experience delivering innovative solutions to the pharmaceutical industry, and his proven track record of growing businesses make him ideally suited to lead Veranova as it prepares for its next phase of growth.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics